2016
DOI: 10.7860/jcdr/2016/18516.7513
|View full text |Cite
|
Sign up to set email alerts
|

An Unusual Origin of Fetal Lymphangioma Filling Right Axilla

Abstract: A 36-year-old multiparous (gravida 4, para 2, dilatation and curettage 1) pregnant woman who admitted to our perinatology outpatient clinic, because of a fetal right-sided septated axillar mass revealed by ultrasonographic investigation at 22 nd week of gestation. The mass had a multilocular structure and well-circumscribed borders and had a measure that was 5x7x7cm in three dimensions. It was originating from the fetal chest wall, and filling the right fetal axilla. The colour Doppler ultrasonographic examina… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 13 publications
(22 citation statements)
references
References 18 publications
0
22
0
Order By: Relevance
“…17 In six publications, the initial dose of sirolimus was not reported. 15,18,19,22,25,28 The target blood level of sirolimus was similar (£15 ng/mL), but slightly differed between the studies. The target blood level was 10-15 ng/mL in seven studies, 8,12,18,22,23,26,27 5-15 ng/mL in four studies, 21,24,29,30 10-13 ng/mL in one study, 16 and 4-8 ng/mL in one study.…”
Section: Treatment With Sirolimusmentioning
confidence: 93%
See 2 more Smart Citations
“…17 In six publications, the initial dose of sirolimus was not reported. 15,18,19,22,25,28 The target blood level of sirolimus was similar (£15 ng/mL), but slightly differed between the studies. The target blood level was 10-15 ng/mL in seven studies, 8,12,18,22,23,26,27 5-15 ng/mL in four studies, 21,24,29,30 10-13 ng/mL in one study, 16 and 4-8 ng/mL in one study.…”
Section: Treatment With Sirolimusmentioning
confidence: 93%
“…Through these methods, 20 articles were identified, containing a total of 71 cases in which sirolimus was used to treat lymphatic malformations, venolymphatic malformations, and capillary-lymphatico-venous malformations. 8,[12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] After identifying these articles, all text and figures were carefully assessed for relevant data. The following information on study characteristics and clinical treatments was extracted from all included studies: publication metrics (name of first author and year of publication), subject information (age, gender, and localization of malformation), and treatment information (sirolimus dose, planned target trough level, treatment duration, treatment outcomes, additional therapies, and adverse events).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…We searched PubMed, Scopus, and the Web of Science for all consecutive cases of fetal axillary cystic hygroma or lymphangioma as well as hemangiolymphangioma. Up to May 2017, 25 cases of axillary lymphangioma were published, as presented in Table . The review included only cystic hygromas and lymphangiomas mainly located at the axilla, but they might extend to the chest wall, the neck, or even the thorax.…”
Section: Literature Review and Analysismentioning
confidence: 99%
“…Up to May 2017, 25 cases of axillary lymphangioma were published, as presented in Table 1. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] The review included only cystic hygromas and lymphangiomas mainly located at the axilla, but they might extend to the chest wall, the neck, or even the thorax. Together with 5 our own cases, a total of 30 cases were analyzed and summarized as follows: be taken into account for decisions on the route of delivery.…”
Section: Literature Review and Analysismentioning
confidence: 99%